| __timestamp | Iovance Biotherapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 2242216 |
| Thursday, January 1, 2015 | 15470000 | 4536244 |
| Friday, January 1, 2016 | 28037000 | 5184803 |
| Sunday, January 1, 2017 | 71615000 | 3068742 |
| Monday, January 1, 2018 | 99828000 | 7178000 |
| Tuesday, January 1, 2019 | 166023000 | 16267000 |
| Wednesday, January 1, 2020 | 201727000 | 23191000 |
| Friday, January 1, 2021 | 259039000 | 21453000 |
| Saturday, January 1, 2022 | 294781000 | 15265000 |
| Sunday, January 1, 2023 | 344077000 | 25189000 |
Unleashing the power of data
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Iovance Biotherapeutics, Inc. and Soleno Therapeutics, Inc. have shown contrasting approaches to R&D spending. From 2014 to 2023, Iovance Biotherapeutics has consistently outpaced Soleno Therapeutics, with R&D expenses growing by over 12,000% from 2014 to 2023. In 2023 alone, Iovance's R&D spending was approximately 13 times higher than Soleno's. This significant investment reflects Iovance's commitment to advancing its pipeline of cancer therapies. Meanwhile, Soleno's more modest R&D growth, peaking in 2023, suggests a focused yet cautious approach. As the biotech industry continues to evolve, these spending patterns highlight the strategic priorities of each company, offering insights into their future potential and innovation trajectories.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.